| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Arzu Soybilgic | |
| Cassyanne L Aguiar | |||
| Tadej Avcin | |||
| Barry L Myones | |||
| P2860 | cites work | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 |
| Assessment of the 2006 revised antiphospholipid syndrome classification criteria | Q24648632 | ||
| Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease | Q26825077 | ||
| IgG placental transfer in healthy and pathological pregnancies | Q27025979 | ||
| Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke | Q28167141 | ||
| A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke | Q28192128 | ||
| Prophylaxis of the antiphospholipid syndrome: a consensus report | Q28196923 | ||
| Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals | Q28210153 | ||
| Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals | Q28217805 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology | Q31001994 | ||
| Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients | Q33239982 | ||
| Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. | Q33329434 | ||
| Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions | Q33341892 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome | Q33344042 | ||
| Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? | Q33367182 | ||
| Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome | Q33367754 | ||
| Neonatal thromboembolic emergencies | Q33370452 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| Congenital Prothrombotic Disorders in Children with Peripheral Venous and Arterial Thromboses | Q57276013 | ||
| Estimation of Antiphospholipid Antibodies in a Prospective Longitudinal Study of Children with Migraine | Q61480456 | ||
| Anticardiolipin response in acute infections | Q69588484 | ||
| Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH | Q70897451 | ||
| Lupus anticoagulant in children with thrombosis | Q72157280 | ||
| Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE | Q72267433 | ||
| Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease | Q73082485 | ||
| Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women | Q73235510 | ||
| Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients | Q73461520 | ||
| Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis | Q73585774 | ||
| Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease | Q73690590 | ||
| Outcome of primary antiphospholipid syndrome in childhood | Q73694057 | ||
| Correction for age of anticardiolipin antibodies cut-off points | Q73748107 | ||
| Antiphospholipid antibodies in children without and in adults with and without thrombophilia | Q73815951 | ||
| Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis | Q73867179 | ||
| Origin of antiphospholipid antibodies: induction of aPL by viral peptides | Q77549928 | ||
| Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy | Q77730465 | ||
| Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples | Q80223750 | ||
| Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura | Q80350620 | ||
| A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus | Q80607286 | ||
| Neuropsychological development of children born to patients with antiphospholipid syndrome | Q80800729 | ||
| European register of babies born to mothers with antiphospholipid syndrome | Q80863098 | ||
| Pediatric reference intervals for seven common coagulation assays | Q81112150 | ||
| Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus | Q81484675 | ||
| Anti-β₂-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? | Q82033286 | ||
| Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome | Q82859979 | ||
| Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study | Q83178270 | ||
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies | Q83389363 | ||
| European registry of babies born to mothers with antiphospholipid syndrome: a result update | Q84387877 | ||
| Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea | Q85339890 | ||
| Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome | Q95376657 | ||
| Antiphospholipid syndrome and recurrent thrombosis in children | Q33373464 | ||
| Antiphospholipid antibodies in Turkish children with thrombosis | Q33375108 | ||
| Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients | Q33375598 | ||
| Antiphospholipid syndrome in pediatrics | Q33377008 | ||
| Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome | Q33380949 | ||
| Treatment, survival, and thromboembolic outcomes of thrombotic storm in children | Q33401175 | ||
| Clinical significance of lupus anticoagulants in children | Q33505107 | ||
| Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives | Q33563205 | ||
| Prevalence of anticardiolipin antibodies in juvenile chronic arthritis | Q33563829 | ||
| Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome | Q33741607 | ||
| Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants | Q33875897 | ||
| Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review | Q34014540 | ||
| Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I. | Q34069117 | ||
| Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis | Q34107416 | ||
| Antiphospholipid syndrome and the brain in pediatric and adult patients | Q34307502 | ||
| 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends | Q34400373 | ||
| Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura | Q34517844 | ||
| Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations | Q34566952 | ||
| Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature | Q34977289 | ||
| Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome | Q35555909 | ||
| The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies | Q36229639 | ||
| Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. | Q36538192 | ||
| European registry of babies born to mothers with antiphospholipid syndrome | Q36550832 | ||
| Pediatric antiphospholipid syndrome | Q36552703 | ||
| Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome | Q36670044 | ||
| Antiphospholipid antibodies in response to infection | Q36832529 | ||
| Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome | Q36915667 | ||
| Infant perinatal thrombosis and antiphospholipid antibodies: a review | Q36915670 | ||
| Placental transfer of immunoglobulin G subclasses | Q36932762 | ||
| Increased anti-phospholipid antibodies in autism spectrum disorders | Q37224652 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment | Q37249537 | ||
| Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome | Q37738701 | ||
| Catastrophic antiphospholipid syndrome: updated diagnostic algorithms | Q37778890 | ||
| Infections and vaccines in the etiology of antiphospholipid syndrome | Q38012320 | ||
| When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). | Q38013584 | ||
| Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature | Q38038986 | ||
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab | Q38115382 | ||
| Common acquired causes of thrombosis in children | Q38124434 | ||
| Pediatric thrombophilia. | Q38163080 | ||
| The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes | Q38206947 | ||
| De novo neonatal antiphospholipid syndrome: a case report and review of the literature. | Q38211924 | ||
| Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. | Q38280730 | ||
| The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus | Q38446538 | ||
| Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients | Q39900861 | ||
| Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab | Q39933698 | ||
| The Ped-APS Registry: the antiphospholipid syndrome in childhood | Q39956194 | ||
| Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. | Q40032766 | ||
| Is Sydenham's chorea an antiphospholipid syndrome? | Q40413797 | ||
| Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection | Q40492266 | ||
| Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome | Q40774311 | ||
| Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature | Q40970929 | ||
| Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis | Q41537096 | ||
| Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis | Q41819349 | ||
| Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report | Q41980805 | ||
| Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry". | Q43456912 | ||
| Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome | Q43616486 | ||
| Risk factors associated with thrombosis in patients with antiphospholipid antibodies. | Q43733233 | ||
| IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations | Q43740415 | ||
| Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo | Q43882937 | ||
| Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome. | Q43976585 | ||
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome | Q44588720 | ||
| Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies | Q45077755 | ||
| Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome? | Q45864129 | ||
| Antiphospholipid syndrome in Mexican children. | Q47381293 | ||
| Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome | Q47689291 | ||
| RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin. | Q47824460 | ||
| Effects of Mothers' Autoimmune Disease During Pregnancy on Learning Disabilities and Hand Preference in Their Children | Q47974068 | ||
| Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome | Q48694365 | ||
| The antiphospholipid (Hughes') syndrome: changing the face of neurology. | Q50479104 | ||
| Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. | Q50619255 | ||
| Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. | Q51120650 | ||
| Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy. | Q51743799 | ||
| Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. | Q51836286 | ||
| Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. | Q52207241 | ||
| Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2)glycoprotein-I antibodies in a healthy infant population. | Q53316978 | ||
| Do we need an international consensus statement on classification criteria for the antiphospholipid syndrome in the paediatric population? | Q53318745 | ||
| Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. | Q53325327 | ||
| Anticardiolipin antibodies in childhood rheumatic disorders. | Q54623349 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 27 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Pediatric antiphospholipid syndrome | |
| P478 | volume | 17 |
| Q26825971 | Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? |
| Q89986376 | Pediatric APS: State of the Art |
| Q90192728 | Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies |
| Q91715407 | Pediatric antiphospholipid syndrome |
| Q59807283 | The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome |
| Q38951210 | What is known about pediatric antiphospholipid syndrome? |
Search more.